本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioAge Labs Inc.

4.20
+0.07001.69%
盤後4.200.00000.00%16:05 EDT
成交量:15.49萬
成交額:64.75萬
市值:1.51億
市盈率:-0.63
高:4.25
開:4.11
低:4.11
收:4.13
資料載入中...
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/04

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/30

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/27

重要事件披露

Form 8-K - Current report
2024/09/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/25

SEC問詢函

Form CORRESP - Correspondence
2024/09/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/23

SEC問詢函

Form CORRESP - Correspondence
2024/09/23

SEC問詢函

Form CORRESP - Correspondence
2024/09/18

SEC問詢函

Form CORRESP - Correspondence
2024/09/18

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/13

SEC問詢函

Form CORRESP - Correspondence
2024/09/04

SEC問詢函

Form CORRESP - Correspondence